1. Home
  2. MAA vs NBIX Comparison

MAA vs NBIX Comparison

Compare MAA & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mid-America Apartment Communities Inc.

MAA

Mid-America Apartment Communities Inc.

HOLD

Current Price

$132.64

Market Cap

15.3B

Sector

Real Estate

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$133.11

Market Cap

15.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAA
NBIX
Founded
1977
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.3B
15.2B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
MAA
NBIX
Price
$132.64
$133.11
Analyst Decision
Buy
Strong Buy
Analyst Count
18
21
Target Price
$154.83
$177.05
AVG Volume (30 Days)
1.0M
1.1M
Earning Date
02-04-2026
02-05-2026
Dividend Yield
4.56%
N/A
EPS Growth
6.34
12.44
EPS
4.71
4.19
Revenue
$2,203,402,000.00
$2,682,700,000.00
Revenue This Year
$1.82
$23.68
Revenue Next Year
$2.02
$18.47
P/E Ratio
$28.47
$31.65
Revenue Growth
0.92
19.61
52 Week Low
$125.75
$84.23
52 Week High
$173.38
$160.18

Technical Indicators

Market Signals
Indicator
MAA
NBIX
Relative Strength Index (RSI) 41.92 33.49
Support Level $134.19 $134.20
Resistance Level $139.15 $142.16
Average True Range (ATR) 2.56 2.92
MACD -0.65 -1.12
Stochastic Oscillator 2.37 8.52

Price Performance

Historical Comparison
MAA
NBIX

About MAA Mid-America Apartment Communities Inc.

Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Share on Social Networks: